Suppr超能文献

白血病中表观遗传修饰的动力学。

Dynamics of epigenetic modifications in leukemia.

机构信息

Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08003, Spain.

出版信息

Brief Funct Genomics. 2011 Jan;10(1):18-29. doi: 10.1093/bfgp/elr002. Epub 2011 Jan 21.

Abstract

Chromatin modifications at both histones and DNA are critical for regulating gene expression. Mis-regulation of such epigenetic marks can lead to pathological states; indeed, cancer affecting the hematopoietic system is frequently linked to epigenetic abnormalities. Here, we discuss the different types of modifications and their general impact on transcription, as well as the polycomb group of proteins, which effect transcriptional repression and are often mis-regulated. Further, we discuss how chromosomal translocations leading to fusion proteins can aberrantly regulate gene transcription through chromatin modifications within the hematopoietic system. PML-RARa, AML1-ETO and MLL-fusions are examples of fusion proteins that mis-regulate epigenetic modifications (either directly or indirectly), which can lead to acute myeloblastic leukemia (AML). An in-depth understanding of the mechanisms behind the mis-regulation of epigenetic modifications that lead to the development and progression of AMLs could be critical for designing effective treatments.

摘要

染色质修饰在组蛋白和 DNA 上对于调节基因表达至关重要。这种表观遗传标记的失调可能导致病理状态;事实上,影响造血系统的癌症通常与表观遗传异常有关。在这里,我们讨论了不同类型的修饰及其对转录的一般影响,以及多梳蛋白组蛋白,其影响转录抑制,并且经常失调。此外,我们还讨论了导致融合蛋白的染色体易位如何通过造血系统内的染色质修饰异常调节基因转录。PML-RARa、AML1-ETO 和 MLL 融合蛋白是异常调节表观遗传修饰(直接或间接)的融合蛋白的例子,可导致急性髓细胞性白血病(AML)。深入了解导致 AML 发生和发展的表观遗传修饰失调的机制对于设计有效的治疗方法可能至关重要。

相似文献

1
Dynamics of epigenetic modifications in leukemia.
Brief Funct Genomics. 2011 Jan;10(1):18-29. doi: 10.1093/bfgp/elr002. Epub 2011 Jan 21.
2
Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Blood. 2012 Oct 11;120(15):3058-68. doi: 10.1182/blood-2011-10-386086. Epub 2012 Aug 24.
3
Definition of a small core transcriptional circuit regulated by AML1-ETO.
Mol Cell. 2021 Feb 4;81(3):530-545.e5. doi: 10.1016/j.molcel.2020.12.005. Epub 2020 Dec 30.
4
A distinct epigenetic signature at targets of a leukemia protein.
BMC Genomics. 2007 Feb 1;8:38. doi: 10.1186/1471-2164-8-38.
6
MLL translocations, histone modifications and leukaemia stem-cell development.
Nat Rev Cancer. 2007 Nov;7(11):823-33. doi: 10.1038/nrc2253.
7
Learning from mouse models of MLL fusion gene-driven acute leukemia.
Biochim Biophys Acta Gene Regul Mech. 2020 Aug;1863(8):194550. doi: 10.1016/j.bbagrm.2020.194550. Epub 2020 Apr 19.
10
Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.
Oncogene. 2004 May 24;23(24):4249-54. doi: 10.1038/sj.onc.1207673.

引用本文的文献

2
Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: how alterations in DNA methylation come into play in patients' prognosis.
J Cancer Res Clin Oncol. 2020 Dec;146(12):3097-3109. doi: 10.1007/s00432-020-03407-3. Epub 2020 Sep 27.
3
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
Oncotarget. 2016 Aug 30;7(35):57327-57350. doi: 10.18632/oncotarget.10033.
6
Targeting Histone Deacetylases in Diseases: Where Are We?
Antioxid Redox Signal. 2015 Jul 1;23(1):99-126. doi: 10.1089/ars.2013.5776. Epub 2014 Mar 6.
7
HDAC3 is essential for DNA replication in hematopoietic progenitor cells.
J Clin Invest. 2013 Jul;123(7):3112-23. doi: 10.1172/JCI60806. Epub 2013 Jun 10.
8
TET proteins: on the frenetic hunt for new cytosine modifications.
Brief Funct Genomics. 2013 May;12(3):191-204. doi: 10.1093/bfgp/elt010. Epub 2013 Apr 26.
9
Mechanisms of epigenetic regulation of leukemia onset and progression.
Adv Immunol. 2013;117:1-38. doi: 10.1016/B978-0-12-410524-9.00001-3.
10
Chromatin remodeling in cancer: a gateway to regulate gene transcription.
Mol Oncol. 2012 Dec;6(6):611-9. doi: 10.1016/j.molonc.2012.09.005. Epub 2012 Oct 22.

本文引用的文献

3
The molecular signature of oncofusion proteins in acute myeloid leukemia.
FEBS Lett. 2010 Jun 18;584(12):2662-9. doi: 10.1016/j.febslet.2010.04.002. Epub 2010 Apr 11.
5
Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells.
Cell. 2009 Dec 24;139(7):1303-14. doi: 10.1016/j.cell.2009.12.003.
7
DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.
Cancer Cell. 2010 Jan 19;17(1):13-27. doi: 10.1016/j.ccr.2009.11.020. Epub 2010 Jan 7.
8
Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.
Blood. 2009 Dec 24;114(27):5415-25. doi: 10.1182/blood-2008-10-182071. Epub 2009 Oct 1.
9
DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells.
Cell Stem Cell. 2009 Oct 2;5(4):442-9. doi: 10.1016/j.stem.2009.08.016.
10
PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.
Leukemia. 2009 Aug;23(8):1462-71. doi: 10.1038/leu.2009.63. Epub 2009 Mar 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验